Edition:
United Kingdom

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

599.15INR
6:35am BST
Change (% chg)

Rs5.70 (+0.96%)
Prev Close
Rs593.45
Open
Rs591.90
Day's High
Rs605.00
Day's Low
Rs590.10
Volume
1,331,684
Avg. Vol
6,834,053
52-wk High
Rs679.30
52-wk Low
Rs435.00

Latest Key Developments (Source: Significant Developments)

India's Sun Pharma Sees Low Double-Digit Topline Growth In FY 2018-19 Consol Revenues
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Sun Pharmaceutical Industries Ltd ::SEES A LOW DOUBLE-DIGIT TOPLINE GROWTH IN CO'S CONSOLIDATED REVENUES FOR FISCAL 2018-19 OVER LAST YEAR.SUN PHARMACEUTICAL INDUSTRIES - EXPECT NORMALIZATION OF THE INDIA BUSINESS IN THE CURRENT YEAR POST THE DISRUPTION LAST YEAR DUE TO GST IMPLEMENTATION.SUN PHARMACEUTICAL INDUSTRIES - EXPECTING REASONABLE GROWTH IN EMERGING MARKETS BUSINESS, HOWEVER, CURRENCY FLUCTUATIONS CONTINUE TO BE A RISK.SHORT-TERM OUTLOOK FOR U.S. GENERICS MARKET CONTINUES TO BE CHALLENGING GIVEN THE PRICING PRESSURES.  Full Article

Sun Pharma Industries Gets Australian Regulator Approval For Psoriasis Drug
Friday, 21 Sep 2018 

Sept 21 (Reuters) - Sun Pharmaceutical Industries Ltd ::RECEIVED AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION APPROVAL FOR SPECIALITY PRODUCT, ILUMYA.SUN PHARMACEUTICAL INDUSTRIES- DRUG FOR TREATMENT OF ADULTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS WHO ARE CANDIDATES FOR SYSTEMIC THERAPY.  Full Article

Sun Pharma Announces U.S. FDA Approval Of Cequa To Treat Dry Eye Disease
Thursday, 16 Aug 2018 

Aug 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMA ANNOUNCES U.S. FDA APPROVAL OF CEQUA™ TO TREAT DRY EYE DISEASE.  Full Article

Sun Pharmaceutical Industries Says Sales In U.S. Were $380 Mln In Q1, Up 8 Pct
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS SALES IN THE U.S WERE US$ 380 MILLION FOR THE QUARTER, A GROWTH OF 8% OVER SAME PERIOD LAST YEAR.SUN PHARMACEUTICAL INDUSTRIES - CREATING PIPELINE OF SPECIALTY PRODUCTS; DURING THE YEAR LAUNCHES WILL RESULT IN SIGNIFICANT UPFRONT INVESTMENTS.  Full Article

India's Sun Pharmaceutical Industries Posts June Qtr Consol Profit
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::JUNE QUARTER CONSOL NET PROFIT 9.83 BILLION RUPEES VERSUS LOSS OF 4.25 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR JUNE QUARTER CONSOL PROFIT WAS 8.97 BILLION RUPEES.JUNE QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 72.24 BILLION RUPEES VERSUS 62.09 BILLION RUPEES LAST YEAR.  Full Article

Sun Pharmaceutical Industries Launches Novel Drug Kapspargo Sprinkle In USA
Monday, 6 Aug 2018 

Aug 6 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS CO LAUNCHES NOVEL DRUG KAPSPARGO SPRINKLE IN USA.  Full Article

India's Sun Pharmaceutical Industries Gets U.S. FDA Nod For INFUGEM Injection
Wednesday, 18 Jul 2018 

July 18 (Reuters) - Sun Pharmaceutical Industries Ltd ::GETS U.S. FDA APPROVAL FOR INFUGEM INJECTION.  Full Article

Beijing Science Sun Pharmaceutical sees FY 2018 H1 net profit up 5 pct to 35 pct
Friday, 13 Jul 2018 

July 13(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ> : :Sees FY 2018 H1 net profit to increase by 5 percent to 35 percent, or to be 110.6 million yuan to 142.2 million yuan.Says FY 2017 H1 net profit was 105.3 million yuan.The reasons for the forecast are improved marketing promotion and enhanced internal management .  Full Article

Sun Pharmaceutical Unit Files Lawsuit Against Biofrontera For Patent Infringement
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Biofrontera AG ::SUN PHARMACEUTICAL INDUSTRIES LTD - CO'S UNIT, DUSA PHARMACEUTICALS FILES LAWSUIT AGAINST BIOFRONTERA FOR PATENT INFRINGEMENT.SUN PHARMACEUTICAL INDUSTRIES - LAWSUIT ALLEGES PATENT INFRINGEMENT OF DUSA'S PATENTS, US 9,723,991 AND US 8,216,289.  Full Article

US FDA Says Issues Voluntary Action Indicated Status To India's Sun Pharma On Halol Drug Plant
Friday, 8 Jun 2018 

June 8 (Reuters) - Sun Pharmaceutical Industries Ltd ::US FDA SAYS ISSUES VOLUNTARY ACTION INDICATED STATUS TO INDIA'S SUN PHARMA ON HALOL DRUG PLANT.  Full Article

Indian shares edge up, head for worst weekly drop since mid-May

Sept 7 Indian shares edged higher on Friday, supported by gains in energy and auto stocks, but were headed for their biggest weekly drop since mid-May as a depreciating rupee soured investor sentiment.